Speech Title: Use of MCDA framework for value assessment of innovative therapies
Bertalan Németh MSc graduated from the Corvinus University of Budapest (MSc in Quantitative economics and Operation research) and the Eötvös Loránd University (Pharmaceutical economics and drug policies). His PhD procedure is ongoing at Semmelweis University. Between 2010 and 2015 he was a health economist at the Hungarian HTA office. Since August 2015 Bertalan has been a Senior Health Economist, and since 2019 a Principal Researcher at Syreon Research Institute. Bertalan is responsible for international relations, and he is involved in various projects that model for economic evaluation in health, health technology assessment and health statistics as well. Bertalan is the Past President of ISPOR Hungary Chapter, and Chair-Elect of the ISPOR CEE Consortium. He was a participant in the international EUnetHTA project, the ISPOR HTA Roundtable Europe, and the Scientific Committee of the META Conference. Bertalan was also a faculty member of the global ISPOR HTA Training, and was the module leader of Health Technology Assessment for the master’s program at Eötvös Loránd University.